CEA Blood Test (Carcinoembryonic Antigen): Normal & High

The CEA blood test measures carcinoembryonic antigen, a protein released into the blood that is grouped among the tumor markers. The label sounds frightening, so let's be clear from the start: a high CEA is not a diagnosis of cancer. This test is used mainly to monitor a cancer that is already known — above all colorectal cancer — and not to screen healthy people for cancer. Many benign conditions raise it, and smoking is the single most common cause. This guide explains the normal CEA level, what a high CEA means, why smoking and inflammation push it up, and how it is used after colon cancer surgery — without the alarm. Like any lab value, a CEA result is read in context, never alone, and never without your clinician.

Key takeaways

• Carcinoembryonic antigen (CEA) is a protein, not a tumor. It is a signal to interpret, not a diagnosis.¹²
• Rough reference points: 0–3 ng/mL in nonsmokers and up to 5 ng/mL in smokers — the same ng/mL unit is used worldwide, and cutoffs vary by lab.²³
• A high CEA is often benign. Smoking is the biggest non-cancer cause; others include IBD (Crohn's, ulcerative colitis), peptic ulcer, pancreatitis, COPD, benign liver disease, and diverticulitis.²⁴
• CEA is not a screening test for colorectal cancer. It misses some cancers and rises in many benign states, so colonoscopy and stool tests (FIT) — not CEA — are the screens.⁵⁶
• Its main job is monitoring: after colon cancer surgery, a rising CEA can be an early sign of recurrence, while a falling CEA suggests treatment is working. The trend matters more than any single number.⁵⁷⁸
• CEA can also rise in other cancers (pancreatic, gastric, lung, breast, medullary thyroid), which makes it non-specific — only your physician can interpret it alongside imaging and your history.¹⁶

Normal CEA levels

There is no single universal "normal," but laboratories use broadly similar reference points, and the key variable is whether you smoke. The Cleveland Clinic gives these commonly used bands:²

Good to know: the usual unit is ng/mL (identical to µg/L), so there is no conversion between U.S. and international results. Smoking raises CEA, which is why the "normal" ceiling is higher for smokers. A CEA that sits just above the cutoff and stays stable — especially in a smoker — is usually unremarkable. What counts as much as the number is its change over time and the clinical picture, not a single hard line.²⁸

What is carcinoembryonic antigen (CEA)?

Carcinoembryonic antigen is a protein made mainly during fetal development, in the tissues of the digestive tract. Production drops sharply after birth, so healthy adults have only a little in their blood.⁴ Its name comes from the fact that it was first identified in cancerous colon tissue, which earned it the "tumor marker" label. But that label is misleading: CEA is neither specific to cancer nor specific to any one organ.¹⁶

In practice, many benign situations push CEA up — smoking first among them, which raises it in a dose-dependent way (hence the different cutoffs for smokers and nonsmokers).² Conversely, some cancers do not raise CEA at all. That is exactly why a CEA level is never read in isolation: it is one signal among several, useful chiefly within a defined clinical context set by your doctor.

What the CEA test is used for

Clinicians order a CEA for a few well-defined reasons — and monitoring, not screening, is the heart of it:⁵⁶

• To monitor a known colorectal cancer: a baseline is often measured before surgery, then repeated afterward to judge the response to treatment and to catch a possible recurrence early.⁷⁵
• To help with prognosis and staging in newly diagnosed colorectal cancer — a markedly high pre-treatment CEA tends to signal more advanced disease.⁶
• To follow other cancers in which it is sometimes used (stomach, pancreas, lung, breast), always alongside other tests.¹

What CEA is not: a way to screen a person without symptoms for cancer. Professional guidelines are explicit that CEA should not be used to screen for or diagnose colorectal cancer, because it lacks the sensitivity and specificity a screening test needs.⁶⁵ The American Cancer Society puts it plainly: tumor-marker blood tests "can't be used alone to screen for or diagnose cancer."⁵

Interpreting your results

High CEA

A high CEA understandably worries people, but the usual explanations are not cancer. Benign causes are common and include:²⁴

• Cigarette smoking — the most frequent cause of a mildly raised CEA;
• Digestive inflammation — inflammatory bowel disease (Crohn's, ulcerative colitis), diverticulitis, gastritis and peptic ulcer;
• Benign liver disease — cirrhosis, fatty liver, gallstones, or blocked bile ducts;
• Lung conditions — COPD, chronic bronchitis, pneumonia;
• Other states — pancreatitis, diabetes, and some infections.

In concrete terms, a CEA "above 5" in a smoker, or a modest elevation that stays stable, is rarely a cause for alarm. A clearly high value (often above 10 ng/mL) or one that is climbing deserves medical attention — calmly. It is your physician who weighs the number against your smoking status, your medical history, and, when needed, imaging.⁸²

The most common myth — "high CEA equals cancer" — is simply wrong, for two reasons. First, most elevations are benign (see above). Second, a normal CEA does not rule out cancer: some tumors produce no CEA at all.¹⁴ Both facts are why CEA fails as a stand-alone test and why the result is always folded into a larger picture.

CEA is not a cancer screening test

This deserves its own honest section, because it is the point most easily misunderstood. CEA is not a screening test for colorectal cancer. Screening means testing people without symptoms to catch disease early — and CEA is poorly suited to it on both counts that matter:⁶⁵

• It is not sensitive enough: many early colorectal cancers, and some advanced ones, do not raise CEA, so a normal result would give false reassurance.⁵
• It is not specific enough: smoking, inflammation, and liver or lung disease raise it in people who have no cancer, generating anxiety and unnecessary tests.²⁴

For colorectal cancer, screening relies on entirely different tools — a colonoscopy or a stool-based test such as the FIT — chosen with your clinician.⁵ CEA earns its keep after a cancer is diagnosed, as a monitoring tool, not before. If a CEA was drawn out of general worry and came back mildly high, that is a prompt for context and, if warranted, appropriate follow-up — not evidence of cancer.

CEA in colorectal cancer monitoring

This is where CEA is genuinely useful. In someone treated for colorectal cancer, CEA is measured before surgery to establish a baseline, then tracked during follow-up. The logic is straightforward: if CEA was elevated before the operation and then falls toward normal, that is reassuring; if it later rises during surveillance, it can be an early warning of recurrence — sometimes months before symptoms — prompting imaging (CT scan) and colonoscopy.⁷⁸ It is the trend over time (the kinetics), far more than any isolated value, that carries the information.⁸

Professional bodies recommend periodic CEA testing during the first years after curative surgery for higher-stage colon cancer, typically alongside scheduled imaging, as part of a structured follow-up plan tailored to the individual.⁶ A rising CEA is a signal to investigate, not a verdict — the confirmation comes from imaging and, if needed, biopsy, interpreted by your oncology team.

Why smoking and benign conditions raise CEA

Understanding why CEA rises without cancer removes much of the fear. CEA is produced by the same kinds of epithelial (lining) cells found throughout the gut and airways, and anything that irritates, inflames, or damages those tissues can nudge more of the protein into the blood.²⁴

Smoking is the standout example. Tobacco smoke chronically irritates the lining of the airways, and smokers carry measurably higher baseline CEA than nonsmokers — in a dose-dependent way. This is precisely why laboratories apply a higher normal ceiling (up to 5 ng/mL) for smokers: the elevation is expected and benign.² The same principle explains the other causes — IBD and diverticulitis inflame the bowel, COPD and pneumonia inflame the lung, and cirrhosis or fatty liver impair the organ that helps clear CEA. None of these involves a tumor, yet all can lift the number above a nonsmoker's range. Tell your clinician if you smoke or have any chronic condition: it changes how the result should be read.

What can raise CEA (besides cancer)

Several factors move CEA and should be mentioned to your clinician: smoking (the most important in routine practice); inflammatory bowel disease, diverticulitis, gastritis and peptic ulcer; benign liver disease (cirrhosis, fatty liver, gallstones); COPD and other lung disease; pancreatitis, diabetes, and some infections; and the laboratory method itself, which is why CEA should ideally be tracked at the same lab over time.²⁴ CEA can also be raised in cancers other than colorectal — pancreatic, gastric, lung, breast, and medullary thyroid cancer among them — which is what makes it a non-specific marker and reinforces that no single value is meaningful on its own.¹⁶ Because CEA rises in liver disease and with liver metastases, results are sometimes read alongside liver enzymes such as GGT or ALT, and inflammation markers such as CRP help put a modest elevation in context.

Recent research

According to recent PubMed publications and clinical-trial evidence:

• Structured surveillance detects more operable recurrences — but with limits. The large British FACS trial showed that follow-up using CEA and/or CT after colorectal cancer surgery finds more surgically treatable recurrences, with no clear added benefit from combining both tests.⁷ More recently, the French PRODIGE-13 trial found no overall survival gain from adding CEA or intensive imaging to standard follow-up, meaning surveillance intensity should be discussed case by case with the oncologist.⁹ (Lepage C et al., Ann Oncol, 2025.)
• Circulating tumor DNA is emerging beyond CEA. Because CEA can stay normal even when cancer returns, researchers are testing circulating tumor DNA (ctDNA) to detect minimal residual disease more finely.¹⁰ In the DYNAMIC trial, a ctDNA-guided strategy after stage II colon cancer surgery safely reduced chemotherapy use without hurting recurrence-free survival — a sign of where surveillance is heading.¹¹ (Tie J et al., N Engl J Med, 2022.)

These findings concern monitoring and research; they do not authorize self-medication and do not replace your physician's advice.

Get your CEA interpreted by AI DiagMe

A CEA is never read alone: its meaning depends on whether you smoke, your medical history (liver, bowel, lung), how it has moved over time, and the wider clinical picture. A high CEA does not equal cancer, and a normal CEA does not rule it out. That cross-referencing is what gives the result its real value.

👉 AI DiagMe interprets your lab results — blood, urine, or stool — in plain language, taking your whole profile into account. An informational service that does not provide a diagnosis and complements, never replaces, your physician.

Frequently asked questions

Bottom line

The CEA blood test measures carcinoembryonic antigen, a tumor marker that is not a cancer test: it rises for benign reasons — smoking, IBD, liver and lung disease — far more often than for a tumor. There is no rigid universal cutoff, but rough guides are 0–3 ng/mL in nonsmokers and up to 5 ng/mL in smokers, with values varying by lab. CEA is not a screening test for colorectal cancer — colonoscopy and FIT are — and its real value lies in monitoring a known colorectal cancer, where a rising trend can flag recurrence early. A high CEA is not a diagnosis, and a normal CEA does not rule cancer out. No value is read alone: it is the full picture — your smoking status, history, trend, and imaging — that counts, which is what AI DiagMe provides, alongside your physician. See also the related tumor markers AFP, CA 125, and PSA.

Sources

Official sources and peer-reviewed publications (PubMed) used for this guide: